[1]
|
杨小福, 黄荷凤. GnRH拮抗剂在控制性超促排卵中的应用[J]. 国外医学(计划生育分册), 2001, 20(4): 231-233, 252. https://doi.org/10.3969/j.issn.1674-1889.2001.04.011
|
[2]
|
Lainas, G.T., Kolibianakis, E.M., Sfontouris, I.A., et al. (2014) Serum Vascular Endothelial Growth Factor Levels Following Luteal Gonadotrophin-Releasing Hormone Antagonist Administration in Women with Severe Early Ovarian Hyperstimulation Syndrome. BJOG, 121, 848-855. https://doi.org/10.1111/1471-0528.12572
|
[3]
|
胡琳莉, 黄国宁, 孙海翔, 等. 辅助生殖技术临床关键指标质控专家共识[J]. 生殖医学杂志, 2018, 27(9): 828-835. https://doi.org/10.3969/j.issn.1004-3845.2018.09.002
|
[4]
|
中华医学会生殖医学分会. 促性腺激素释放激素拮抗剂方案在辅助生殖领域中使用的专家共识[J]. 中华妇产科杂志, 2015(11): 805-809.
|
[5]
|
Itskovitz-Eldor, J., Kol, S. and Mannaerts, B. (2000) Use of a Single Bolus of GnRH Agonist Triptorelin to Trigger Ovulation after GnRH Antagonist Ganirelix Treatment in Women Undergoing Ovarian Stimulation for Assisted Reproduction, with Special Reference to the Prevention of Ovarian Hyperstimulation Syndrome: Preliminary Report: Short Communication. Human Reproduction, 15, 1965-1968. https://doi.org/10.1093/humrep/15.9.1965
|
[6]
|
Lin, H., Li, Y., Li, L., et al. (2014) Is a GnRH Antagonist Protocol Better in PCOS Patients? A Meta-Analysis of RCTs. PLOS ONE, 9, e91796. https://doi.org/10.1371/journal.pone.0091796
|
[7]
|
Al-Inany, H.G., Youssef, M.A., Aboulghar, M., et al. (2011) GnRH Antagonists Are Safer than Agonists: An Update of a Cochrane Review. Human Reproduction Update, 17, 435. https://doi.org/10.1093/humupd/dmr004
|
[8]
|
Pu, D., Wu, J. and Liu, J. (2011) Comparisons of GnRH Antagonist versus GnRH Agonist Protocol in Poor Ovarian Responders Undergoing IVF. Human Reproduction, 26, 2742-2749. https://doi.org/10.1093/humrep/der240
|
[9]
|
Pandian, Z., McTavish, A.R., Aucott, L., et al. (2010) Interventions for “Poor Responders” to Controlled Ovarian Hyper Stimulation (COH) in In-Vitro Fertilisation (IVF). Cochrane Database of Systematic Reviews, No. 1, CD004379.
https://doi.org/10.1002/14651858.CD004379.pub3
|
[10]
|
牛婷, 李爱斌, 曹景云, 陈力, 沈兰. GnRH拮抗剂方案及GnRH-a短方案用于卵巢低反应患者助孕临床疗效Meta分析[J]. 生殖医学杂志, 2015, 24(4): 281-288.
|
[11]
|
Wang, R., Lin, S., Wang, Y., Qian, W. and Zhou, L. (2017) Comparisons of GnRH Antagonist Protocol versus GnRH Agonist Long Protocol in Patients with Normal Ovarian Reserve: A Systematic Review and Me-ta-Analysis. PLOS ONE, 12, e0175985. https://doi.org/10.1371/journal.pone.0175985
|
[12]
|
姜薇, 倪丹玉, 李欣, 等. 促性腺激素释放激素长方案和拮抗剂方案促排卵冻融胚胎移植周期结局的比较[J]. 国际生殖健康/计划生育杂志, 2022, 41(2): 101-105.
|
[13]
|
Xia, M. and Zheng, J. (2021) Comparison of Clinical Outcomes between the Depot Gonadotrophin-Releasing Hormone Agonist Protocol and Gonadotrophin-Releasing Hormone Antagonist Protocol in Normal Ovarian Responders. BMC Pregnancy Childbirth, 21, 372. https://doi.org/10.1186/s12884-021-03849-8
|
[14]
|
张争, 蒋承芳, 李玉艳, 等. 正常反应人群拮抗剂方案与激动剂长方案的临床特点及结局比较[J]. 陆军军医大学学报, 2022, 44(5): 484-488. https://doi.org/10.16016/j.2097-0927.202107177
|
[15]
|
Haouzi, D., Assou, S., Dechanet, C., et al. (2010) Con-trolled Ovarian Hyperstimulation for in Vitro Fertilization Alters Endometrial Receptivity in Humans: Protocol Effects. Biology of Reproduction, 82, 679-686.
https://doi.org/10.1095/biolreprod.109.081299
|
[16]
|
杨柳, 李丽斐, 张晓梅, 张学红. 黄体酮阴道缓释凝胶对比安琪坦胶囊作为IVF/ICSI-ET黄体支持疗效的Meta分析[J]. 现代妇产科进展, 2017, 26(6): 440-444. https://doi.org/10.13283/j.cnki.xdfckjz.2017.06.031
|
[17]
|
葛芬芬, 徐键. 辅助生殖技术中的黄体支持[J]. 国外医学(计划生育/生殖健康分册), 2007, 26(5): 239-243.
https://doi.org/10.3969/j.issn.1674-1889.2007.05.002
|
[18]
|
孙赟, 刘平, 叶虹, 等. 黄体支持与孕激素补充共识[J]. 生殖与避孕, 2015, 35(1): 1-8.
https://doi.org/10.7669/j.issn.0253-357X.2015.01.0001
|
[19]
|
Bjuresten, K., Landgren, B.M., Hovatta, O. and Stavreus-Evers, A. (2011) Luteal Phase Progesterone Increases Live Birth Rate after Frozen Embryo Transfer. Fertility and Sterility, 95, 534-537.
https://doi.org/10.1016/j.fertnstert.2010.05.019
|
[20]
|
Pritts, E.A. and Atwood, A.K. (2002) Luteal Phase Support in Infertility Treatment: A Meta-Analysis of the Randomized Trials. Human Reproduction, 17, 2287-2299. https://doi.org/10.1093/humrep/17.9.2287
|
[21]
|
薛亚梅, 童晓嵋, 张松英. 黄体酮肌肉注射与阴道缓释凝胶对IVF-ET结局影响的Meta分析[J]. 生殖与避孕, 2015, 35(4): 252-258. https://doi.org/10.7669/j.issn.0253-357X.2015.04.0252
|
[22]
|
Schoolcraft, W.B., Hesla, J.S. and Gee, M.J. (2000) Experience with Progesterone Gel for Luteal Support in a Highly Successful IVF Programme. Human Reproduction, 15, 1284-1288. https://doi.org/10.1093/humrep/15.6.1284
|
[23]
|
迟洪滨, 周灿权, 王树玉, 等. 黄体酮阴道缓释凝胶在IVF/ICSI周期中作为黄体支持的初步应用[J]. 实用妇产科杂志, 2012, 28(11): 973-976.
|
[24]
|
陈兰媚, 张文金, 张绵新, 等. IVF/ICSI-ET术患者胚胎移植后不同黄体支持用药的护理指导[J]. 国际护理学杂志, 2017, 36(8): 1147-1149. https://doi.org/10.3760/cma.j.issn.1673-4351.2017.08.047
|
[25]
|
Simunic, V., Tomic, V., Tomic, J. and Nizic, D. (2007) Comparative Study of the Efficacy and Tolerability of Two Vaginal Progesterone Formulations, Crinone 8% Gel and Utrogestan Capsules, Used for Luteal Support. Fertility and Sterility, 87, 83-87. https://doi.org/10.1016/j.fertnstert.2006.05.067
|
[26]
|
Orvieto, R., Meltcer, S., Volodarski, M., et al. (2007) Luteal Phase Support for Patients Undergoing Frozen-Thawed Embryo Transfer Cycles—The Required Progesterone Dose. Clinical and Experimental Obstetrics & Gynecology, 34, 25-26.
|
[27]
|
Alsbjerg, B., Polyzos, N.P., Elbaek, H.O., et al. (2013) Increasing Vaginal Progesterone Gel Supplementation after Frozen-Thawed Embryo Transfer Significantly In-creases the Delivery Rate. Reproductive BioMedicine Online, 26, 133- 137. https://doi.org/10.1016/j.rbmo.2012.10.012
|
[28]
|
Tavaniotou, A. and Devroey, P. (2006) Luteal Hormonal Profile of Oocyte Donors Stimulated with a GnRH Antagonist Compared with Natural Cycles. Reproductive BioMedicine Online, 13, 326-330.
https://doi.org/10.1016/S1472-6483(10)61435-6
|
[29]
|
Fatemi, H.M., Kolibianakis, E.M., Camus, M., et al. (2006) Addition of Estradiol to Progesterone for Luteal Supplementation in Patients Stimulated with GnRH Antagonist/rFSH for IVF: A Randomized Controlled Trial. Human Reproduction, 21, 2628-2632. https://doi.org/10.1093/humrep/del117
|
[30]
|
Kwon, S.K., Kim, C.H., Lee, K.H., et al. (2013) Luteal Estradiol Sup-plementation in Gonadotropin-Releasing Hormone Antagonist Cycles for Infertile Patients in Vitro Fertilization. Clinical and Experimental Reproductive Medicine, 40, 131-134. https://doi.org/10.5653/cerm.2013.40.3.131
|
[31]
|
Ismail Madkour, W.A., Noah, B., Abdel Hamid, A.M., et al. (2016) Luteal Phase Support with Estradiol and Progesterone versus Progesterone Alone in GnRH Antagonist ICSI Cycles: A Randomized Controlled Study. Human Fertility, 19, 142-149. https://doi.org/10.1080/14647273.2016.1200145
|
[32]
|
Engmann, L., DiLuigi, A., Schmidt, D., et al. (2008) The Effect of Luteal Phase Vaginal Estradiol Supplementation on the Success of in Vitro Fertilization Treatment: A Prospective Randomized Study. Fertility and Sterility, 89, 554-561.
https://doi.org/10.1016/j.fertnstert.2007.04.006
|
[33]
|
陈峦峦, 司徒冰, 李斯晨, 等. 辅助生殖技术患者在促性腺激素释放激素拮抗剂方案补充雌二醇疗效的Meta分析[J]. 中南药学, 2019, 17(12): 2180-2185. https://doi.org/10.7539/j.issn.1672-2981.2019.12.038
|
[34]
|
Huang, N., Situ, B., Chen, X., et al. (2015) Me-ta-Analysis of Estradiol for Luteal Phase Support in in Vitro Fertilization/Intracytoplasmic Sperm Injection. Fertility and Sterility, 103, 367-373.e5.
https://doi.org/10.1016/j.fertnstert.2014.10.029
|
[35]
|
Ceyhan, S.T., Basaran, M., Kemal Duru, N., et al. (2008) Use of Luteal Estrogen Supplementation in Normal Responder Patients Treated with Fixed Multidose GnRH Antagonist: A Prospective Randomized Controlled Study. Fertility and Sterility, 89, 1827-1830. https://doi.org/10.1016/j.fertnstert.2007.08.029
|
[36]
|
Gizzo, S. andrisani, A., Esposito, F., et al. (2014) Which Lute-al Phase Support Is Better for Each IVF Stimulation Protocol to Achieve the Highest Pregnancy Rate? A Superiority Randomized Clinical Trial. Gynecological Endocrinology, 30, 902-908. https://doi.org/10.3109/09513590.2014.964638
|
[37]
|
高洪伟. 绒毛膜促性腺激素的分子特性及其临床应用[J]. 药品评价, 2014, 11(5): 33-37.
|
[38]
|
Youssef, M.A., Van der Veen, F., Al-Inany, H.G., et al. (2014) Gonadotro-pin-Releasing Hormone Agonist versus HCG for Oocyte Triggering in Antagonist-Assisted Reproductive Technology. Cochrane Database of Systematic Reviews, No. 10, CD008046. https://doi.org/10.1002/14651858.CD008046.pub4
|
[39]
|
Wong, K.M., van Wely, M., Mol, F., et al. (2017) Fresh versus Frozen Embryo Transfers in Assisted Reproduction. Cochrane Database of Systematic Reviews, 3, CD011184. https://doi.org/10.1002/14651858.CD011184.pub2
|
[40]
|
Humaidan, P., Bungum, L., Bungum, M. and Yding, A.C. (2006) Rescue of Corpus Luteum Function with Peri-Ovulatory HCG Supplementation in IVF/ICSI GnRH Antagonist Cycles in Which Ovulation Was Triggered with a GnRH Agonist: A Pilot Study. Reproductive BioMedicine Online, 13, 173-178. https://doi.org/10.1016/S1472-6483(10)60612-8
|
[41]
|
Humaidan, P., Ejdrup Bredkjaer, H., Westergaard, L.G. and Yding, A.C. (2010) 1,500 IU Human Chorionic Gonadotropin Administered at Oocyte Retrieval Rescues the Luteal Phase when Gonadotropin-Releasing Hormone Agonist Is Used for Ovulation Induction: A Prospective, Ran-domized, Controlled Study. Fertility and Sterility, 93, 847-854.
https://doi.org/10.1016/j.fertnstert.2008.12.042
|
[42]
|
Humaidan, P., Polyzos, N.P., Alsbjerg, B., et al. (2013) GnRHa Trigger and Individualized Luteal Phase hCG Support According to Ovarian Response to Stimulation: Two Prospective Randomized Controlled Multi-Centre Studies in IVF Patients. Human Reproduction, 28, 2511-2521. https://doi.org/10.1093/humrep/det249
|
[43]
|
劳群秀, 谢重驹, 卢海英, 杨美琼. 拮抗剂方案应用人绒毛膜促性腺激素黄体支持的临床研究[J]. 中国处方药, 2021, 19(1): 1-4.
|
[44]
|
Radesic, B. and Tremellen, K. (2011) Oocyte Maturation Employing a GnRH Agonist in Combination with Low-Dose hCG Luteal Rescue Minimizes the Severity of Ovarian Hyperstimulation Syndrome while Maintaining Excellent Pregnancy Rates. Human Reproduction, 26, 3437-3442. https://doi.org/10.1093/humrep/der333
|
[45]
|
Youssef, M.A., Abdelmoty, H.I., Ahmed, M.A. and Elmohamady, M. (2015) GnRH Agonist for Final Oocyte Maturation in GnRH Antagonist Co-Treated IVF/ICSI Treat-ment Cycles: Systematic Review and Meta-Analysis. Journal of Advanced Research, 6, 341-349. https://doi.org/10.1016/j.jare.2015.01.005
|
[46]
|
Seyhan, A., Ata, B., Polat, M., et al. (2013) Severe Early Ovarian Hyperstimulation Syndrome Following GnRH Agonist Trigger with the Addition of 1500 IU hCG. Human Reproduc-tion, 28, 2522-2528.
https://doi.org/10.1093/humrep/det124
|
[47]
|
Haas, J., Kedem, A., Machtinger, R., et al. (2014) HCG (1500IU) Administration on Day 3 after Oocytes Retrieval, Following GnRH-Agonist Trigger for Final Follicular Maturation, Re-sults in High Sufficient Mid Luteal Progesterone Levels—A Proof of Concept. Journal of Ovarian Research, 7, 35. https://doi.org/10.1186/1757-2215-7-35
|
[48]
|
Pirard, C., Donnez, J. and Loumaye, E. (2006) GnRH Agonist as Luteal Phase Support in Assisted Reproduction Technique Cycles: Results of a Pilot Study. Human Reproduction, 21, 1894-1900. https://doi.org/10.1093/humrep/del072
|
[49]
|
Tesarik, J., Hazout, A. and Mendoza, C. (2004) Enhance-ment of Embryo Developmental Potential by a Single Administration of GnRH Agonist at the Time of Implantation. Human Reproduction, 19, 1176-1180.
https://doi.org/10.1093/humrep/deh235
|
[50]
|
Isik, A.Z., Caglar, G.S., Sozen, E., et al. (2009) Single-Dose GnRH Agonist Administration in the Luteal Phase of GnRH Antagonist Cycles: A Prospective Randomized Study. Reproduc-tive BioMedicine Online, 19, 472-477.
https://doi.org/10.1016/j.rbmo.2009.04.001
|
[51]
|
Zafardoust, S., Jeddi-Tehrani, M., Akhondi, M.M., et al. (2015) Effect of Administration of Single Dose GnRH Agonist in Luteal Phase on Outcome of ICSI-ET Cycles in Women with Previous History of IVF/ICSI Failure: A Randomized Controlled Trial. Journal of Reproduction & Infertility, 16, 96-101.
|
[52]
|
余璐萍, 刘宁, 刘英. 促性腺激素释放激素激动剂用于辅助生殖技术黄体支持的荟萃分析[J]. 中华妇产科杂志, 2016, 51(11): 850-858. https://doi.org/10.3760/cma.j.issn.0529-567X.2016.11.010
|
[53]
|
Aboulghar, M.A., Marie, H., Amin, Y.M., et al. (2015) GnRH Agonist plus Vaginal Progesterone for Luteal Phase Support in ICSI Cycles: A Randomized Study. Reproductive BioMedicine Online, 30, 52-56.
https://doi.org/10.1016/j.rbmo.2014.09.017
|
[54]
|
曲丹妮, 王鹏, 李媛. 促性腺激素释放激素激动剂在体外受精-胚胎移植患者黄体支持中的应用[J]. 吉林大学学报(医学版), 2021, 47(3): 701-706. https://doi.org/10.13481/j.1671-587X.20210321
|
[55]
|
Bar-Hava, I., Mizrachi, Y., Karfunkel-Doron, D., et al. (2016) Intranasal Gonadotropin-Releasing Hormone Agonist (GnRHa) for Luteal-Phase Support Following GnRHa Triggering, a Novel Approach to Avoid Ovarian Hyperstimulation Syndrome in High Responders. Fertility and Sterility, 106, 330-333.
https://doi.org/10.1016/j.fertnstert.2016.04.004
|
[56]
|
Martins, W.P., Ferriani, R.A., Navarro, P.A. and Nastri, C.O. (2016) GnRH Agonist during Luteal Phase in Women Undergoing Assisted Reproductive Techniques: Systematic Re-view and Meta-Analysis of Randomized Controlled Trials. Ultrasound in Obstetrics & Gynecology, 47, 144-151. https://doi.org/10.1002/uog.14874
|